Literature DB >> 12791578

Low-dose vasopressin in the treatment of septic shock in sheep.

Qinghua Sun1, George Dimopoulos, Duc Nam Nguyen, Zizhi Tu, Nathalie Nagy, Anh Dung Hoang, Peter Rogiers, Daniel De Backer, Jean-Louis Vincent.   

Abstract

After induction of cecal perforation, 20 anesthetized sheep were randomized to be treated, when arterial blood pressure fell below 75 mm Hg, with vasopressin (fixed dose of 0.02 U/minute), norepinephrine (0.5-5 microg/kg/minute titrated to maintain mean arterial pressure between 75 and 85 mm Hg), vasopressin + norepinephrine (vasopressin at fixed dose 0.01 U/minute plus norepinephrine titrated as for norepinephrine only group), or no vasopressor (Ringer's lactate [control]). Mean arterial pressure was well maintained in all treatment groups. Superior mesenteric arterial blood flow was significantly lower in the vasopressin + norepinephrine group than in the vasopressin group. Vasopressin alone or combined with norepinephrine limited the increase in blood lactate concentration and ileal PCO2-gap compared with control and norepinephrine groups. Urine output was higher in the vasopressin group than in control and norepinephrine groups. Survival time was longer in the vasopressin (30 +/- 6 hours) and vasopressin + norepinephrine (30 +/- 3 hours) groups than in the norepinephrine group (20 +/- 1 hours, p < 0.05) and in all treatment groups than in the control group (17 +/- 2 hours, p < 0.05). Tissue injury was less severe in the vasopressin and vasopressin + norepinephrine groups than in the others. In this clinically relevant model of septic shock due to peritonitis, vasopressin administration (alone or with norepinephrine) can prolong survival.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12791578     DOI: 10.1164/rccm.200205-447OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  21 in total

1.  Effects of combined levosimendan and vasopressin on pulmonary function in porcine septic shock.

Authors:  Muhuo Ji; Renqi Li; Guo-min Li; Yunxia Fan; Lin Dong; Jianjun Yang; Yong G Peng; Jing Wu
Journal:  Inflammation       Date:  2012-06       Impact factor: 4.092

2.  Vasopressin and splanchnic blood flow: vasoconstriction does not equal vasoconstriction in every organ.

Authors:  P Asfar; P Radermacher; B Hauser
Journal:  Intensive Care Med       Date:  2005-11-18       Impact factor: 17.440

3.  Gender differences in the effects of antenatal betamethasone exposure on renal function in adult sheep.

Authors:  Lijun Tang; Luke C Carey; Jianli Bi; Nancy Valego; Xiurong Sun; Philip Deibel; James Perrott; Jorge P Figueroa; Mark C Chappell; James C Rose
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-11-26       Impact factor: 3.619

4.  Hemodynamic management of septic shock.

Authors:  Daniel De Backer
Journal:  Curr Infect Dis Rep       Date:  2006-09       Impact factor: 3.725

5.  The selective vasopressin type 1a receptor agonist selepressin (FE 202158) blocks vascular leak in ovine severe sepsis*.

Authors:  Marc O Maybauer; Dirk M Maybauer; Perenlei Enkhbaatar; Régent Laporte; Halina Wiśniewska; Lillian D Traber; ChiiDean Lin; Juanjuan Fan; Hal K Hawkins; Robert A Cox; Kazimierz Wiśniewski; Claudio D Schteingart; Donald W Landry; Pierre J-M Rivière; Daniel L Traber
Journal:  Crit Care Med       Date:  2014-07       Impact factor: 7.598

6.  Comparison of cardiac, hepatic, and renal effects of arginine vasopressin and noradrenaline during porcine fecal peritonitis: a randomized controlled trial.

Authors:  Florian Simon; Ricardo Giudici; Angelika Scheuerle; Michael Gröger; Pierre Asfar; Josef A Vogt; Ulrich Wachter; Franz Ploner; Michael Georgieff; Peter Möller; Régent Laporte; Peter Radermacher; Enrico Calzia; Balázs Hauser
Journal:  Crit Care       Date:  2009-07-10       Impact factor: 9.097

7.  Selective V(1a) agonism attenuates vascular dysfunction and fluid accumulation in ovine severe sepsis.

Authors:  Sebastian Rehberg; Yusuke Yamamoto; Linda Sousse; Eva Bartha; Collette Jonkam; Anthony K Hasselbach; Lillian D Traber; Robert A Cox; Martin Westphal; Perenlei Enkhbaatar; Daniel L Traber
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-09-07       Impact factor: 4.733

Review 8.  Vasopressin vs. terlipressin in the treatment of cardiovascular failure in sepsis.

Authors:  Matthias Lange; Christian Ertmer; Martin Westphal
Journal:  Intensive Care Med       Date:  2007-12-08       Impact factor: 17.440

9.  Systemic and hepatosplanchnic macro- and microcirculatory dose response to arginine vasopressin in endotoxic rabbits.

Authors:  Tal Kopel; Marie-Reine Losser; Valérie Faivre; Didier Payen
Journal:  Intensive Care Med       Date:  2008-03-26       Impact factor: 17.440

10.  Arginine vasopressin in septic shock: supplement or substitute for norepinephrine?

Authors:  Sebastian Rehberg; Perenlei Enkhbaatar; Daniel L Traber
Journal:  Crit Care       Date:  2009-08-14       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.